Kura Oncology (KURA) Return on Equity [ROE] (2015 - 2026)
Kura Oncology (KURA) recorded Return on Equity [ROE] of -379.72% in Q2 2026, down 321.45 percentage points from -58.26% a year earlier and down 170.81 percentage points from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Kura Oncology reported Return on Equity [ROE] of -94.82%, down 51.91 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for three straight years, with a three-year change of -65.51 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -42.91% in FY2024 (-5.57 pp), -37.34% in FY2023 (-8.03 pp) and -29.31% in FY2022.
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q1 2024.
- On a year-over-year basis, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -115.54 percentage points over the last six quarters.
- Per Business Quant, the preceding three quarters came in at -208.90% (Q1 2026), -133.76% (Q4 2025) and -78.41% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Kura Oncology | 695.52 Mn | -1.56 Bn | 22.47 Mn | -838,738.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -838,738.90% |
| Jun 30, 2026 | -356,239.74% |
| Mar 31, 2026 | -197,450.88% |
| Dec 31, 2025 | -133,631.57% |
| Sep 30, 2025 | -62,768.01% |
| Jun 30, 2025 | -51,343.22% |
| Mar 31, 2025 | -44,202.05% |
| Dec 31, 2024 | -41,066.57% |
| Sep 30, 2024 | -32,796.20% |
| Jun 30, 2024 | -30,046.96% |
| Mar 31, 2024 | -32,334.68% |
| Dec 31, 2023 | -35,267.95% |
| Sep 30, 2023 | -30.82% |
| Jun 30, 2023 | -32.11% |
| Mar 31, 2023 | -33.53% |
| Dec 31, 2022 | -33.83% |
| Sep 30, 2022 | -33.30% |
| Jun 30, 2022 | -30.41% |
| Mar 31, 2022 | -28.24% |
| Dec 31, 2021 | -25.43% |
API Access
Kura Oncology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();